Exposure to airborne pollutants, which is rising as a result of climate change, appears to increase the risk of Parkinson’s disease, according to a review study into how a changing environment can affect human health. Air pollutants and other aspects of climate change also were found to associate with…
People with Parkinson’s disease who underwent acupuncture for eight weeks had significantly lower levels of anxiety at a follow-up visit two months later than those who received a sham procedure, a clinical trial from China reported. Trial findings also suggested that acupuncture may be an effective way to improve…
A new analysis using machine-learning and sensor data from the Parkinson’s Progression Markers Initiative (PPMI), a digital health research program sponsored by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), successfully distinguished between people with and without Parkinson’s disease, according to a small study led by…
Very high levels of levodopa — a compound commonly prescribed to treat Parkinson’s disease — were detected in some over-the-counter supplements with extracts from Mucuna pruriens, a type of bean that naturally contains levodopa, a study has found. In many of the tested supplements, the amount of levodopa…
Physical activity may be beneficial to brain health, including for people with neurodegenerative diseases such as Parkinson’s disease, by promoting increases in brain volume, a long-term follow-up study suggests. “Our study results indicate that even small behavioral changes, such as walking 15 minutes a day or taking the stairs…
ZyVersa Therapeutics announced that a grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) will support work into IC 100 as a potential antibody-based therapy for Parkinson’s disease. Robert Keane, PhD, and Juan Pablo de Rivero Vaccari, PhD, professors at the University of…
Kyowa Kirin has discontinued the clinical development of its investigational treatment, KW-6356, for Parkinson’s disease, despite Phase 2 clinical trial data showing promising results as a monotherapy or in combination with levodopa. The decision was based on the “global regulatory landscape, development hurdles, and timelines for potential market…
A new method for turning specific human stem cells, called pluripotent stem cells, into neurons that can produce dopamine — the signaling molecule, essential for controlling movement, that is missing in patients with Parkinson’s disease — has now been developed by researchers in the U.S. “Scientists have been trying…
Biogen and Alectos Therapeutics have signed an exclusive license and collaboration agreement to further develop and commercialize AL01811, a small molecule therapy, as a potential treatment for Parkinson’s disease. “Through this collaboration with Alectos, we hope to improve the lives of people living with Parkinson’s disease by advancing…
Accidental falls and co-existing conditions, or comorbidities, like fatigue, depression, and sleeping problems are frequent in older adults with either Parkinson’s disease or essential tremor syndrome, suggesting “similar central origins” for these two disorders, a study reported. Its data also support essential tremor being found in older Parkinson’s patients, and Parkinson’s in those…
Get regular updates to your inbox.